Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- Hope Biosciences LLC
- Study ID
- NCT06654193
- Phase
- PHASE1/PHASE2
- Status
- Recruiting
Conditions
- Acute Kidney Injury
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Allogeneic HB-adMSCs — DRUGAllogeneic HB-adMSCs
- Normal Saline — DRUGSterile Saline Solution
Study Details
This study aims to investigate, through the collection of valid scientific evidence necessary to determine safety and effectiveness, the potential use of Allogeneic Hope Biosciences Adipose-derived Mesenchymal Stem Cells (HB-adMSCs) to prevent progression of trauma-induced Acute Kidney Injury (AKI).
Key Dates
- Start date
- Feb 1, 2026
- Status verified
- Mar 2026
- Primary completion
- Jan 1, 2028
- Completion
- Jan 1, 2028
Study Design
- Enrollment
- 70 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Placebo Comparator: PlaceboNormal saline
- Experimental: TreatmentAllogeneic adipose-derived HB-adMSCs
Primary Outcome Measure
Incidence of infusion-related adverse events (AEs) or serious adverse events (SAEs) [ Time Frame: 1 year ]
Central Contacts
- Charles S Cox, Jr., MD713-500-7307
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35294 | Sabrina Goddard, MD Sabrina Goddard, MD (PRINCIPAL_INVESTIGATOR) John B Holcomb, MD (SUB_INVESTIGATOR) |
| University of California, San Francisco | San Francisco | California | 94143 | Joseph Cuschieri, MD Joseph Cuschieri, MD (PRINCIPAL_INVESTIGATOR) Shibani Pati, MD, PhD (PRINCIPAL_INVESTIGATOR) Kathleen Liu, MD, PhD (SUB_INVESTIGATOR) Lucy Kornblith, MD (SUB_INVESTIGATOR) |
| University of Texas Health Science Center at Houston (UTHealth Houston) | Houston | Texas | 77479 | Charles S Cox, Jr., Dr. (PRINCIPAL_INVESTIGATOR) Erin E Fox, PhD (SUB_INVESTIGATOR) John Harvin, MD, MS (SUB_INVESTIGATOR) Laura Moore, MD (SUB_INVESTIGATOR) Claudia Pedroza, PhD (SUB_INVESTIGATOR) |
Find similar trials in Birmingham, AL
Related Studies
- The Biosonographic IndexRecruiting · University of Alabama at Birmingham · Birmingham, Alabama
- Angiotensin 2 for AKI After OLTPHASE4 · Enrolling By Invitation · University of California, Los Angeles · Los Angeles, California
- Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn RegistryRecruiting · Potrero Medical · Los Angeles, California
- KIDney Injury in Times of COVID-19 (KIDCOV)Recruiting · University of California, San Francisco · San Francisco, California